BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38342816)

  • 1. Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia.
    Aref S; Khaled O; Menshawy NE; Azmy E; Aref M; Salama O; Khaled N
    J Egypt Natl Canc Inst; 2024 Feb; 36(1):5. PubMed ID: 38342816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of embryonic stem cell markers in acute myeloid leukemia.
    Picot T; Aanei CM; Fayard A; Flandrin-Gresta P; Tondeur S; Gouttenoire M; Tavernier-Tardy E; Wattel E; Guyotat D; Campos L
    Tumour Biol; 2017 Jul; 39(7):1010428317716629. PubMed ID: 28718379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma.
    Matsuoka J; Yashiro M; Sakurai K; Kubo N; Tanaka H; Muguruma K; Sawada T; Ohira M; Hirakawa K
    J Surg Res; 2012 May; 174(1):130-5. PubMed ID: 21227461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia.
    Tosic N; Petrovic I; Grujicic NK; Davidovic S; Virijevic M; Vukovic NS; Pavlovic S; Stevanovic M
    Leuk Res; 2018 Apr; 67():32-38. PubMed ID: 29428447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium.
    Song N; Jia XS; Jia LL; Ma XB; Li F; Wang EH; Li X
    Cell Prolif; 2010 Feb; 43(1):49-55. PubMed ID: 19845688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
    Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR
    J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
    Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
    Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the methylation status of the Oct3/4, Nanog, and Sox2 promoters in stem cells during regeneration of rat tracheal epithelium after injury.
    Zhou Y; Song N; Li X; Han Y; Ren Z; Xu JX; Han YC; Li F; Jia X
    Oncotarget; 2017 Jan; 8(2):2984-2994. PubMed ID: 27935870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34
    Wang YY; Chen WL; Weng XQ; Sheng Y; Wu J; Hao J; Liu ZY; Zhu YM; Chen B; Xiong SM; Chen Y; Chen QS; Sun HP; Li JM; Wang J
    Stem Cells Dev; 2017 Oct; 26(20):1460-1467. PubMed ID: 28810819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
    Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
    Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.
    Eissa DS; Kandeel EZ; Ghareeb M
    Hematol Oncol; 2017 Dec; 35(4):814-820. PubMed ID: 27734526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.
    Fujiwara SI; Muroi K; Yamamoto C; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Ozawa K
    Hematology; 2017 Jul; 22(6):347-353. PubMed ID: 28097942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
    Aref S; Salama O; Al-Tonbary Y; Mansour A
    Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
    Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
    Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
    Sannino G; Marchetto A; Ranft A; Jabar S; Zacherl C; Alba-Rubio R; Stein S; Wehweck FS; Kiran MM; Hölting TLB; Musa J; Romero-Pérez L; Cidre-Aranaz F; Knott MML; Li J; Jürgens H; Sastre A; Alonso J; Da Silveira W; Hardiman G; Gerke JS; Orth MF; Hartmann W; Kirchner T; Ohmura S; Dirksen U; Grünewald TGP
    EBioMedicine; 2019 Sep; 47():156-162. PubMed ID: 31427232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
    Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AC133 antigen as a prognostic factor in acute leukemia.
    Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
    Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.
    Eini R; Stoop H; Gillis AJ; Biermann K; Dorssers LC; Looijenga LH
    PLoS One; 2014; 9(1):e83585. PubMed ID: 24404135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.